Dr NUESCH Jürg

Fiche personne

coordonnées

DKFZ (German Cancer Research Center)
Im Neuenheimer Feld 280
69120 HEIDELBERG
Allemagne

+49 6221 424982

jpf.nuesch@dkfz.de

Territoire

Alsace

Statut

Chercheur

affiliation

Deutsches Krebsforschungszentrum (DKFZ)

équipes/plateformes

Equipe Parvovirus Host Cell Interactions

Recherche

Expertises :
- Recherche:Virologie

Publications

Virotherapy in Germany-Recent Activities in Virus Engineering, Preclinical Development, and Clinical Studies.

Nettelbeck DM, Leber MF, Altomonte J, Angelova A, Beil J, Berchtold S, Delic M, Eberle J, Ehrhardt A, Engeland CE, Fechner H, Geletneky K, Goepfert K, Holm PS, Kochanek S, Kreppel F, Krutzke L, Kühnel F, Lang KS, Marchini A, Moehler M, Mühlebach MD, Naumann U, Nawroth R, Nüesch J, Rommelaere J, Lauer UM, Ungerechts G

Viruses. 2021 Jul 21;13(8):

Integrin alpha5beta1 and p53 convergent pathways in the control of anti-apoptotic proteins PEA-15 and survivin in high-grade glioma.

Renner G, Janouskova H, Noulet F, Koenig V, Guerin E, Bar S, Nuesch J, Rechenmacher F, Neubauer S, Kessler H, Blandin AF, Choulier L, Etienne-Selloum N, Lehmann M, Lelong-Rebel I, Martin S, Dontenwill M

Cell Death Differ. 2015 Oct 16

PKCeta/Rdx-driven Phosphorylation of PDK1: A Novel Mechanism Promoting Cancer Cell Survival and Permissiveness for Parvovirus-induced Lysis.

Bar S, Rommelaere J, Nuesch JP

PLoS Pathog. 2015 Mar 5;11(3):e1004703

Tumor suppressive activity of a variant isoform of manganese superoxide dismutase released by a human liposarcoma cell line.

Mancini A, Borrelli A, Schiattarella A, Fasano S, Occhiello A, Pica A, Sehr P, Tommasino M, Nuesch JP, Rommelaere J

Int J Cancer. 2006 Aug 15;119(4):932-43.

NS1 interaction with CKII alpha: novel protein complex mediating parvovirus-induced cytotoxicity.

Nuesch JP, Rommelaere J

J Virol. 2006 May;80(10):4729-39.

Selective alterations of the host cell architecture upon infection with parvovirus minute virus of mice.

Nuesch JP, Lachmann S, Rommelaere J

Virology. 2005 Jan 5;331(1):159-74.

Dr NUESCH Jürg

Fiche personne

coordonnées

Territoire

Statut

affiliation

équipes/plateformes

Recherche

Publications

Virotherapy in Germany-Recent Activities in Virus Engineering, Preclinical Development, and Clinical Studies.

Integrin alpha5beta1 and p53 convergent pathways in the control of anti-apoptotic proteins PEA-15 and survivin in high-grade glioma.

PKCeta/Rdx-driven Phosphorylation of PDK1: A Novel Mechanism Promoting Cancer Cell Survival and Permissiveness for Parvovirus-induced Lysis.

Tumor Selectivity of Oncolytic Parvoviruses: From in vitro and Animal Models to Cancer Patients.

Tumor suppressing properties of rodent parvovirus NS1 proteins and their derivatives.

Vesicular transport of progeny parvovirus particles through ER and Golgi regulates maturation and cytolysis.

Molecular pathways: rodent parvoviruses--mechanisms of oncolysis and prospects for clinical cancer treatment.

Ezrin-radixin-moesin family proteins are involved in parvovirus replication and spreading.

Viral proteins killing tumor cells: new weapons in the fight against cancer.

Vesicular egress of non-enveloped lytic parvoviruses depends on gelsolin functioning.

A viral adaptor protein modulating casein kinase II activity induces cytopathic effects in permissive cells.

Tumor suppressive activity of a variant isoform of manganese superoxide dismutase released by a human liposarcoma cell line.

NS1 interaction with CKII alpha: novel protein complex mediating parvovirus-induced cytotoxicity.

Selective alterations of the host cell architecture upon infection with parvovirus minute virus of mice.